These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

372 related articles for article (PubMed ID: 22563056)

  • 1. Importance of functional and metabolic impairments in the characterization of the C-26 murine model of cancer cachexia.
    Murphy KT; Chee A; Trieu J; Naim T; Lynch GS
    Dis Model Mech; 2012 Jul; 5(4):533-45. PubMed ID: 22563056
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of the renin-angiotensin system improves physiological outcomes in mice with mild or severe cancer cachexia.
    Murphy KT; Chee A; Trieu J; Naim T; Lynch GS
    Int J Cancer; 2013 Sep; 133(5):1234-46. PubMed ID: 23436228
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Muscle-specific E3 ubiquitin ligases are involved in muscle atrophy of cancer cachexia: an in vitro and in vivo study.
    Yuan L; Han J; Meng Q; Xi Q; Zhuang Q; Jiang Y; Han Y; Zhang B; Fang J; Wu G
    Oncol Rep; 2015 May; 33(5):2261-8. PubMed ID: 25760630
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cryptotanshinone prevents muscle wasting in CT26-induced cancer cachexia through inhibiting STAT3 signaling pathway.
    Chen L; Yang Q; Zhang H; Wan L; Xin B; Cao Y; Zhang J; Guo C
    J Ethnopharmacol; 2020 Oct; 260():113066. PubMed ID: 32505837
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diaphragm and ventilatory dysfunction during cancer cachexia.
    Roberts BM; Ahn B; Smuder AJ; Al-Rajhi M; Gill LC; Beharry AW; Powers SK; Fuller DD; Ferreira LF; Judge AR
    FASEB J; 2013 Jul; 27(7):2600-10. PubMed ID: 23515443
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of Stat3 activation suppresses caspase-3 and the ubiquitin-proteasome system, leading to preservation of muscle mass in cancer cachexia.
    Silva KA; Dong J; Dong Y; Dong Y; Schor N; Tweardy DJ; Zhang L; Mitch WE
    J Biol Chem; 2015 Apr; 290(17):11177-87. PubMed ID: 25787076
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of FoxO transcriptional activity prevents muscle fiber atrophy during cachexia and induces hypertrophy.
    Reed SA; Sandesara PB; Senf SM; Judge AR
    FASEB J; 2012 Mar; 26(3):987-1000. PubMed ID: 22102632
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rosiglitazone and imidapril alone or in combination alleviate muscle and adipose depletion in a murine cancer cachexia model.
    Chen SZ; Xiao JD
    Tumour Biol; 2014 Jan; 35(1):323-32. PubMed ID: 23959470
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Valproic acid attenuates skeletal muscle wasting by inhibiting C/EBPβ-regulated atrogin1 expression in cancer cachexia.
    Sun R; Zhang S; Hu W; Lu X; Lou N; Yang Z; Chen S; Zhang X; Yang H
    Am J Physiol Cell Physiol; 2016 Jul; 311(1):C101-15. PubMed ID: 27122162
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of the anticatabolic effects of leucine and Ca-β-hydroxy-β-methylbutyrate in experimental models of cancer cachexia.
    Mirza KA; Pereira SL; Voss AC; Tisdale MJ
    Nutrition; 2014; 30(7-8):807-13. PubMed ID: 24984997
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibody-directed myostatin inhibition enhances muscle mass and function in tumor-bearing mice.
    Murphy KT; Chee A; Gleeson BG; Naim T; Swiderski K; Koopman R; Lynch GS
    Am J Physiol Regul Integr Comp Physiol; 2011 Sep; 301(3):R716-26. PubMed ID: 21677277
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor inoculation site affects the development of cancer cachexia and muscle wasting.
    Matsuyama T; Ishikawa T; Okayama T; Oka K; Adachi S; Mizushima K; Kimura R; Okajima M; Sakai H; Sakamoto N; Katada K; Kamada K; Uchiyama K; Handa O; Takagi T; Kokura S; Naito Y; Itoh Y
    Int J Cancer; 2015 Dec; 137(11):2558-65. PubMed ID: 26016447
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mitochondrial and sarcoplasmic reticulum abnormalities in cancer cachexia: altered energetic efficiency?
    Fontes-Oliveira CC; Busquets S; Toledo M; Penna F; Paz Aylwin M; Sirisi S; Silva AP; Orpí M; García A; Sette A; Inês Genovese M; Olivan M; López-Soriano FJ; Argilés JM
    Biochim Biophys Acta; 2013 Mar; 1830(3):2770-8. PubMed ID: 23200745
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preclinical Investigation of the Novel Histone Deacetylase Inhibitor AR-42 in the Treatment of Cancer-Induced Cachexia.
    Tseng YC; Kulp SK; Lai IL; Hsu EC; He WA; Frankhouser DE; Yan PS; Mo X; Bloomston M; Lesinski GB; Marcucci G; Guttridge DC; Bekaii-Saab T; Chen CS
    J Natl Cancer Inst; 2015 Dec; 107(12):djv274. PubMed ID: 26464423
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Small-Molecule Chemical Knockdown of MuRF1 in Melanoma Bearing Mice Attenuates Tumor Cachexia Associated Myopathy.
    Adams V; Gußen V; Zozulya S; Cruz A; Moriscot A; Linke A; Labeit S
    Cells; 2020 Oct; 9(10):. PubMed ID: 33050629
    [No Abstract]   [Full Text] [Related]  

  • 16. Smad7 gene delivery prevents muscle wasting associated with cancer cachexia in mice.
    Winbanks CE; Murphy KT; Bernardo BC; Qian H; Liu Y; Sepulveda PV; Beyer C; Hagg A; Thomson RE; Chen JL; Walton KL; Loveland KL; McMullen JR; Rodgers BD; Harrison CA; Lynch GS; Gregorevic P
    Sci Transl Med; 2016 Jul; 8(348):348ra98. PubMed ID: 27440729
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Myocardial dysfunction in an animal model of cancer cachexia.
    Xu H; Crawford D; Hutchinson KR; Youtz DJ; Lucchesi PA; Velten M; McCarthy DO; Wold LE
    Life Sci; 2011 Feb; 88(9-10):406-10. PubMed ID: 21167183
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Physiological characterization of a mouse model of cachexia in colorectal liver metastases.
    Murphy KT; Struk A; Malcontenti-Wilson C; Christophi C; Lynch GS
    Am J Physiol Regul Integr Comp Physiol; 2013 May; 304(10):R854-64. PubMed ID: 23485871
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of PARP activity in lung cancer-induced cachexia: Effects on muscle oxidative stress, proteolysis, anabolic markers, and phenotype.
    Chacon-Cabrera A; Mateu-Jimenez M; Langohr K; Fermoselle C; García-Arumí E; Andreu AL; Yelamos J; Barreiro E
    J Cell Physiol; 2017 Dec; 232(12):3744-3761. PubMed ID: 28177129
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Astaxanthin Ameliorates Skeletal Muscle Atrophy in Mice With Cancer Cachexia.
    Yu X; Ren P; Yang R; Yue H; Tang Q; Xue C
    Nutr Cancer; 2024; 76(6):529-542. PubMed ID: 38567899
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.